MTOS represents a series of cutting-edge small molecule drugs with a good safety profile and effective results. Our team comprises highly experienced research staff, primarily former senior researchers from prestigious national laboratories.  The MTOS drug series includes:

• MTOS-I: Broad-spectrum Antiviral New Drug

• MTOS-II: New Drug for XDR/MDR-TB

• MTOS-III: Anti-tumor New Drug

• MTOS-V: Safe Analgesic New Drug